Upgrade to SI Premium - Free Trial

Virpax Pharmaceuticals, Inc. (VRPX) Reports Q1 Loss of $0.13

May 12, 2023 4:45 PM

Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) reported Q1 EPS of ($0.13), versus $0.00 reported last year.

For earnings history and earnings-related data on Virpax Pharmaceuticals, Inc. (VRPX) click here.

Categories

Earnings